comparemela.com

Rachel Vatnsdal Piper Sandler News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CareDx Inc (CDNA) Q4 2020 Earnings Call Transcript

Operator Greetings, and welcome to the CareDx, Inc. Fourth Quarter 2020 Earnings Conference Call. [Operator Instructions] I would now like to turn the conference over to your host, Greg Chodaczek, Managing Director. Greg Chodaczek Investor Relations Good afternoon, and thank you for joining us today. Earlier today, CareDx released financial results for the quarter and year ended December 31, 2020. The release is currently available on the Company s website at www.caredx.com. Reg Seeto, Chief Executive Officer; and Marcel Konrad, Chief Financial Officer will host this afternoon s call. Before we get started, I would like to remind everyone that management will be making statements during this call that include forward-looking statements within the meaning of the federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that are not statements of historical facts

Pacific Biosciences of California (PACB) Q4 2020 Earnings Call Transcript

Operator Thank you for standing by, and welcome to the Pacific Biosciences of California, Inc. fourth-quarter 2020 earnings conference call. [Operator instructions] I would now like to hand the conference over to Trevin Rard. Please go ahead. Trevin Rard Investor Relations Thank you. Good afternoon, and welcome to the Pacific Biosciences fourth-quarter 2020 earnings conference call. We hope that you re keeping well during this time. Earlier today, we issued a press release outlining the financial results we ll be discussing on today s call, a copy of which is available on the Investors section of our website at www.pacb.com or, alternatively, as furnished on Form 8-K available on the Securities and Exchange Commission website at www.sec.gov.

Enanta Pharmaceuticals Inc (ENTA) Q1 2021 Earnings Call Transcript

Operator Good afternoon, and welcome to Enanta Pharmaceuticals First Quarter 2021 Financial Results Conference Call. [Operator Instructions] There will be a question-and-answer session at the end of the prepared remarks. [Operator Instructions] I would now like to turn the conference over to Jennifer Viera, Investor Relations. Please go ahead. Jennifer Viera Investor Relations Thank you, operator, and thank you to everyone for joining us this afternoon. The news release with our fiscal first quarter financial results was issued this afternoon and is available on our website. On the call today is Dr. Jay Luly, President and Chief Executive Officer; Paul Mellett, our Chief Financial Officer; and other members of Enanta s senior management team.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.